Water-soluble mixture and preparation method thereof

Through the combination of cannabidiol and poloxamer, micelle structure is formed, the water solubility of CBD is improved, the problem of insufficient water solubility of CBD is solved, and the preparation of water-soluble mixture without solvent residue is achieved, which is suitable for efficient and safe Drug application.

CN119015266APending Publication Date: 2024-11-26东莞市吉纯生物技术有限公司
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202411087554.X
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-08-08
Publication Date
2024-11-26

Smart Images

  • Figure CN119015266A_ABST
    Figure CN119015266A_ABST
Patent Text Reader

Abstract

The invention discloses a water-soluble mixture and a preparation method thereof. Wherein the mixture is prepared from the following components in parts by mass: 100 to 300 parts of cannabidiol; and 657 to 887 parts of poloxamer. The water-soluble mixture and the preparation method thereof have the beneficial effects that the water solubility of cannabidiol can be improved, and solvent residues can be reduced.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The present application relates to the technical field of pharmaceutical chemistry, and in particular to a water-soluble mixture and a preparation method thereof. Background Art

[0002] At present, CBD, or cannabidiol, is the main active ingredient in cannabis and a secondary metabolite, which is mainly extracted and purified from cannabis flowers and leaves. CBD molecular formula: C 21 H 30 O2, molecular weight: 314.46, light yellow resin or crystal, insoluble in water (solubility in water is about 0.1528ug / mL), easily soluble in ethanol, methanol, ethyl acetate, petroleum ether, chloroform and 10% sodium hydroxide, melting point is 66-67℃. CBD has multiple pharmacological effects: (a) CBD has a certain effect on the inhibition of glioma, leukemia and prostate cancer. CBD has a neuroprotective effect, can reduce the pain of epilepsy, and can inhibit refractory epilepsy and reduce the frequency of epilepsy. (b) Anti-inflammatory and antioxidant. (c) Anti-nausea and vomiting. (d) Hepatoprotective effect: CBD can play a corresponding protective role on ischemic liver damage and liver damage caused by chronic alcohol poisoning, and can reduce liver damage caused by long-term drinking (including increased liver transaminase levels, etc.). (e) Regulate metabolism and enhance immunity: regulate the level of inflammatory factors and inhibit the production of interferon, thereby improving metabolism and immunity; at the same time, it can play a role in the control of diabetes or the treatment of early diabetes. However, due to the problem of CBD's water solubility, the application of CBD is currently greatly limited.

[0003] In the prior art, in order to solve the problem of CBD water solubility, the application and addition of CBD are mostly dissolved in organic solvents or 10% sodium hydroxide solution, and then related subsequent operations are performed, or chemical synthesis methods (such as condensing arginine and CBD to prepare cannabidiol arginine ester) are used to increase water solubility. However, the above methods will cause solvent residues, affecting the quality of CBD products.

[0004] Therefore, how to improve the water solubility of CBD and reduce solvent residues is an urgent problem to be solved in this field. Summary of the invention

[0005] In view of this, the present application provides a water-soluble mixture and a preparation method thereof to at least partially solve the above technical problems.

[0006] The embodiment of the present application is implemented as follows: a water-soluble mixture, wherein the water-soluble mixture comprises, in parts by mass:

[0007] Cannabidiol 100-300 parts;

[0008] Poloxamer 657-887 parts.

[0009] Optionally, in some embodiments of the present application, the ratio of the mass fraction of the poloxamer to the mass fraction of the cannabidiol ranges from 2 to 9.

[0010] Optionally, in some embodiments of the present application, the poloxamer includes one or both of poloxamer 188 and poloxamer 407.

[0011] Optionally, in some embodiments of the present application, the ratio of the mass fraction of the poloxamer to the mass fraction of the cannabidiol ranges from 2.19 to 5.5.

[0012] Optionally, in some embodiments of the present application, the water-soluble mixture comprises, in parts by mass:

[0013]

[0014] Optionally, in some embodiments of the present application, the water-soluble mixture comprises, by mass percentage:

[0015]

[0016] Optionally, in some embodiments of the present application, the stabilizer includes one or more of glycerol, mannitol, erythritol, sorbitol, maltitol, lactitol, and xylitol.

[0017] Optionally, in some embodiments of the present application, the metal complex includes one or more of disodium ethylenediaminetetraacetate, pentasodium diethylenetriaminepentaacetate, trisodium nitrilotriacetate, and tetrasodium ethylene glycol bis(2-aminoethyl ether)tetraacetate.

[0018] Optionally, in some embodiments of the present application, the organic acid includes one or more of formic acid, acetic acid, propionic acid, butyric acid, valeric acid, caproic acid, caprylic acid, capric acid, citric acid, lauric acid, myristic acid, palmitic acid, stearic acid, oleic acid, linoleic acid, linolenic acid, phenylacetic acid, benzoic acid, pyruvic acid, levulinic acid, tartaric acid, lactic acid, malonic acid, succinic acid, fumaric acid, gluconic acid, saccharic acid, salicylic acid, sorbic acid, malonic acid or malic acid.

[0019] Accordingly, the present invention also provides a method for preparing a water-soluble mixture, the method comprising:

[0020] Provide at least cannabidiol and poloxamer;

[0021] Melting the cannabidiol and poloxamer to obtain a material to be solidified;

[0022] The material to be solidified is cooled and solidified to obtain the water-soluble mixture.

[0023] The beneficial effect of the present application is that it provides a water-soluble mixture that can improve the water solubility of cannabidiol and reduce solvent residues and a preparation method thereof.

[0024] More specifically, some embodiments of the present application may produce the following specific beneficial effects:

[0025] By using a combination of cannabidiol and poloxamer, poloxamer can form a micellar structure, fully encapsulate the cannabidiol molecules, form a water-soluble gel of oil-in-water type, and increase the water solubility of cannabidiol through surface activity. The water solubility of CBD in the water-soluble mixture of the present application can reach 20-40 mg / mL. At the same time, no solvent is added in the present application, so the prepared water-soluble mixture has no solvent residue. BRIEF DESCRIPTION OF THE DRAWINGS

[0026] In order to more clearly illustrate the technical solutions in the embodiments of the present application, the drawings required for use in the description of the embodiments will be briefly introduced below. Obviously, the drawings described below are only some embodiments of the present application. For those skilled in the art, other drawings can be obtained based on these drawings without paying any creative work.

[0027] Figure 1 It is a schematic diagram of the main steps of a method for preparing a water-soluble mixture provided in an embodiment of the present application;

[0028] Figure 2 It is a schematic diagram of the specific steps of a method for preparing a water-soluble mixture provided in an embodiment of the present application;

[0029] Figure 3 is a schematic diagram of the appearance of the mixture product prepared in Example 1 of the present application;

[0030] Figure 4 is a schematic diagram of a solution after the mixture product prepared in Example 1 of the present application is dissolved in water;

[0031] Figure 5 This is a schematic diagram of the appearance of the mixture product prepared in Comparative Example 1 of the present application;

[0032] Figure 6 This is a schematic diagram of a solution after the mixture product prepared in Comparative Example 1 of the present application is dissolved in water;

[0033] Figure 7 This is a schematic diagram of the appearance of the mixture product prepared in Comparative Example 2 of the present application;

[0034] Figure 8This is a schematic diagram of a solution after the mixture product prepared in Comparative Example 2 of the present application is dissolved in water;

[0035] Fig. 9 This is a schematic diagram of the appearance of the mixture product prepared in Comparative Example 3 of the present application;

[0036] Fig.10 This is a schematic diagram of a solution after the mixture product prepared in Comparative Example 3 of the present application is dissolved in water;

[0037] Fig.11 This is a schematic diagram of the appearance of the mixture product prepared in Comparative Example 8 of the present application;

[0038] Fig.12 This is a schematic diagram of a solution after the mixture product prepared in Comparative Example 8 of the present application is dissolved in water;

[0039] Fig.13 This is a schematic diagram of the appearance of the mixture product prepared in Comparative Example 9 of the present application;

[0040] Fig.14 It is a schematic diagram of a solution after the mixture product prepared in Comparative Example 9 of the present application is dissolved in water. DETAILED DESCRIPTION

[0041] The technical solutions in the embodiments of the present application will be clearly and completely described below in conjunction with the drawings in the embodiments of the present application. Obviously, the described embodiments are only part of the embodiments of the present application, rather than all of the embodiments. Based on the embodiments in the present application, all other embodiments obtained by those skilled in the art without making creative work belong to the scope of protection of the present application. In addition, it should be understood that the specific implementation methods described herein are only used to illustrate and explain the present application, and are not used to limit the present application.

[0042] Unless otherwise defined, all technical and scientific terms used herein have the same meaning as those commonly understood by those skilled in the art of the present invention. The terms used in the specification of the present invention herein are only for the purpose of describing specific embodiments and are not intended to limit the present invention.

[0043] In this application, in the description of this application, the term "including" means "including but not limited to." The terms first, second, third, etc. are used merely as labels and do not impose numerical requirements or establish a sequence.

[0044] In this application, "and / or" describes the association relationship of associated objects, indicating that there may be three relationships. For example, A and / or B can mean: A exists alone, A and B exist at the same time, and B exists alone. A and B can be singular or plural.

[0045] In the present application, "at least one" means one or more, and "plurality" means two or more. "One or more", "at least one of the following" or similar expressions refer to any combination of these items, including any combination of single items or plural items. For example, "at least one of a, b, or c", or "at least one of a, b, and c" can all mean: a, b, c, ab (i.e., a and b), ac, bc, or abc, where a, b, c can be single or multiple, respectively.

[0046] Various embodiments of the present application may be presented in the form of a range; it should be understood that the description in the form of a range is only for convenience and brevity, and should not be understood as a rigid limitation on the scope of the present application; therefore, the range description should be considered to have specifically disclosed all possible sub-ranges and single numerical values ​​within the range. For example, the range description from 1 to 6 should be considered to have specifically disclosed sub-ranges, such as from 1 to 3, from 1 to 4, from 1 to 5, from 2 to 4, from 2 to 6, from 3 to 6, etc., as well as single numbers within the range, such as 1, 2, 3, 4, 5 and 6, which apply regardless of the range. In addition, whenever a numerical range is indicated herein, it is meant to include any cited number (fractional or integer) within the indicated range.

[0047] The technical solution of this application is as follows:

[0048] In a first aspect, an embodiment of the present application provides a water-soluble mixture, which includes, by weight: 100-300 parts of cannabidiol (CBD) and 657-887 parts of poloxamer (polyoxyethylene-polyoxypropylene ether block copolymer).

[0049] By adopting the above technical solution, a combination of cannabidiol and poloxamer is used, and poloxamer can form a micellar structure, fully encapsulate the cannabidiol molecules, form a water-soluble gel of oil-in-water type, and increase the water solubility of cannabidiol through surface activity. The water solubility of CBD in the water-soluble mixture of the present application can reach 20-40 mg / mL. At the same time, no solvent is added in the present application, so the prepared water-soluble mixture has no solvent residue.

[0050] In some embodiments, the ratio of the mass fraction of poloxamer to the mass fraction of cannabidiol ranges from 2 to 9.

[0051] Specifically, the ratio of the mass fraction of poloxamer to the mass fraction of cannabidiol can be at least one of: 2:1, 3:1, 4:1, 5:1, 6:1, 7:1, 8:1, and 9:1.

[0052] In some embodiments, the poloxamer includes one or both of poloxamer 188 (P188), poloxamer 407 (P407).

[0053] In some embodiments, the ratio of the mass fraction of poloxamer to the mass fraction of cannabidiol ranges from 2.19 to 5.5. By adopting such a ratio range, CBD has better solubility.

[0054] In some embodiments, the water-soluble mixture includes, by weight: 100-300 parts of cannabidiol, 657-887 parts of poloxamer, 10-30 parts of stabilizer, 1-5 parts of metal complex and 2-8 parts of organic acid.

[0055] Such a ratio scheme is adopted, in which the stabilizer is used to keep CBD in a stable form; the metal complex can reduce the catalytic oxidation effect of metal ions on CBD, so that the water-soluble mixture will not oxidize and discolor; the organic acid is used to maintain the acidity of the mixture system, so that the chemical properties of CBD are stable, and CBD will not be transformed into anthraquinone substances under alkaline conditions, causing the product color to change to purple.

[0056] In some embodiments, the water-soluble mixture includes, by mass percentage, 10%-30% cannabidiol, 65.7%-88.7% poloxamer, 1%-3% stabilizer, 0.1%-0.5% metal complex and 0.2%-0.8% organic acid.

[0057] In some embodiments, the stabilizer includes one or more polyols or polysaccharide alcohols such as glycerol, mannitol, erythritol, sorbitol, maltitol, lactitol, and xylitol.

[0058] In some embodiments, the metal complex comprises one or more of disodium ethylenediaminetetraacetate (disodium EDTA), pentasodium diethylenetriaminepentaacetate (pentasodium DTPA), trisodium nitrilotriacetate (trisodium NTA), and tetrasodium ethylene glycol bis(2-aminoethyl ether)tetraacetate (tetrasodium EGTA).

[0059] In some embodiments, the organic acid comprises one or more of formic acid, acetic acid, propionic acid, butyric acid, valeric acid, caproic acid, caprylic acid, capric acid, citric acid, lauric acid, myristic acid, palmitic acid, stearic acid, oleic acid, linoleic acid, linolenic acid, phenylacetic acid, benzoic acid, pyruvic acid, levulinic acid, tartaric acid, lactic acid, malonic acid, succinic acid, fumaric acid, gluconic acid, saccharic acid, salicylic acid, sorbic acid, malonic acid, and malic acid.

[0060] Reference Figure 1 As shown, the present application embodiment also provides a method for preparing a water-soluble mixture, the preparation method comprising:

[0061] S101, provide at least cannabidiol and poloxamer;

[0062] S102, melting cannabidiol and poloxamer to obtain a material to be solidified;

[0063] S103, cooling and solidifying the material to be solidified to obtain a water-soluble mixture.

[0064] Wherein, the material to be solidified is at least a mixture of melted cannabidiol and poloxamer.

[0065] By adopting the above-mentioned preparation scheme, cannabidiol and poloxamer are mixed by a melting method, and no organic solvent needs to be added during the preparation process. The preparation process is simple to operate, convenient to produce, and safe. The obtained water-soluble mixture product has a good shape and is easy to use.

[0066] In one embodiment of the present application, more specifically, referring to Figure 2 As shown, the preparation method of the water-soluble mixture comprises the following specific steps:

[0067] S201, providing cannabidiol, poloxamer, stabilizer, metal complex and organic acid;

[0068] S202, placing cannabidiol, poloxamer, stabilizer, metal complex and organic acid into a reactor, and performing a first stage of stirring at room temperature (25±5° C.) until they are uniform; the stirring time of the first stage of stirring is 5-30 min, and the stirring speed of the first stage of stirring is 600-800 r / min;

[0069] S203, raising the temperature to 70-85° C. and performing a second stage of stirring until the cannabidiol and poloxamer are melted; the stirring time of the second stage of stirring is 4-6 hours, and the stirring speed is 600-800 r / min;

[0070] S204, cooling to room temperature (25±5°C) for solidification, and pulverizing to obtain a mixture product.

[0071] In particular, the reactor may be a glass container.

[0072] The present application is described in detail below by means of specific examples, which are only partial examples of the present application and are not intended to limit the present application. The raw materials used in the following examples are all commercially available products unless otherwise specified.

[0073] Example 1

[0074] (1) Provide the raw materials required for the water-soluble mixture, including 20 g of cannabidiol, 77.1 g of poloxamer (P407), 2.2 g of mannitol, 0.34 g of EDTA-disodium, and 0.36 g of citric acid.

[0075] (2) Cannabidiol, poloxamer (P407), mannitol, EDTA-disodium and citric acid were placed in a glass container and stirred at room temperature (25±5°C) until they were uniform. The stirring time of the first stage stirring was 10 min and the stirring speed was 700±50 r / min.

[0076] (3) Raise the temperature to 75° C. and carry out the second stage of stirring. The stirring time of the second stage of stirring is 5 hours, and the stirring speed is 700±50 r / min, until the cannabidiol and poloxamer are melted.

[0077] (4) cooling to room temperature (25±5°C) for solidification, and pulverizing to obtain a mixture product; Figure 3 As shown, the mixture product is a white powder.

[0078] (5) Take 330 mg of the mixture and dissolve it in 2 mL of water. Figure 4 As shown, the solution is colorless, clear and transparent, and the solubility of CBD is 33 mg / mL.

[0079] Table 1 shows the addition amount of each component and the solubility of CBD in the prepared mixture products in Examples 1 to 14. The processes of Examples 1 to 14 are the same, and the only difference is the addition ratio of each component.

[0080] Table 1

[0081]

[0082] Embodiment 15

[0083] (1) Provide the raw materials required for the water-soluble mixture, including 20 g of cannabidiol, 77.3 g of poloxamer (P188), 2.0 g of mannitol, 0.34 g of EDTA-disodium, and 0.36 g of citric acid.

[0084] (2) Cannabidiol, poloxamer (P188), mannitol, EDTA-disodium and citric acid were placed in a glass container and stirred at room temperature (25±5°C) until they were uniform. The stirring time of the first stage stirring was 10 min and the stirring speed was 700±50 r / min.

[0085] (3) Raise the temperature to 75° C. and carry out the second stage of stirring. The stirring time of the second stage of stirring is 5 hours, and the stirring speed is 700±50 r / min, until the cannabidiol and poloxamer are melted.

[0086] (4) Cool to room temperature (25±5°C) for solidification, and pulverize to obtain a mixture product; the mixture product is a white powder (similar to Example 1).

[0087] (5) 320 mg of the mixture product was added into 2 mL of water and dissolved. The solution was colorless, clear and transparent (similar to Example 1). The solubility of CBD was 32 mg / mL.

[0088] Example 16

[0089] (1) Provide the raw materials required for the water-soluble mixture, including 20 g of cannabidiol, 76.1 g of poloxamer (P407), 3.0 g of xylitol, 0.34 g of disodium EDTA, and 0.36 g of citric acid.

[0090] (2) Cannabidiol, poloxamer (P407), xylitol, disodium EDTA and citric acid were placed in a glass container and stirred at room temperature (25±5°C) until they were uniform. The stirring time of the first stage stirring was 10 min and the stirring speed was 700±50 r / min.

[0091] (3) Raise the temperature to 75° C. and carry out the second stage of stirring. The stirring time of the second stage of stirring is 5 hours, and the stirring speed is 700±50 r / min, until the cannabidiol and poloxamer are melted.

[0092] (4) Cool to room temperature (25±5°C) for solidification, and pulverize to obtain a mixture product; the mixture product is a white powder (similar to Example 1).

[0093] (5) 320 mg of the mixture product was added into 2 mL of water and dissolved. The solution was colorless, clear and transparent (similar to Example 1). The solubility of CBD was 32 mg / mL.

[0094] Embodiment 17

[0095] (1) Provide the raw materials required for the water-soluble mixture, including 20 g of cannabidiol, 77.44 g of poloxamer (P407), 2.0 g of mannitol, 0.2 g of trisodium NTA, and 0.36 g of citric acid.

[0096] (2) Cannabidiol, poloxamer (P407), mannitol, trisodium NTA and citric acid were placed in a glass container and stirred at room temperature (25±5°C) until they were uniform. The stirring time of the first stage was 10 min and the stirring speed was 700±50 r / min.

[0097] (3) Raise the temperature to 75° C. and carry out the second stage of stirring. The stirring time of the second stage of stirring is 5 hours, and the stirring speed is 700±50 r / min, until the cannabidiol and poloxamer are melted.

[0098] (4) Cool to room temperature (25±5°C) for solidification, and pulverize to obtain a mixture product; the mixture product is a white powder (similar to Example 1).

[0099] (5) 330 mg of the mixture product was added into 2 mL of water and dissolved. The solution was colorless, clear and transparent (similar to Example 1). The solubility of CBD was 33 mg / mL.

[0100] Embodiment 18

[0101] (1) Provide the raw materials required for the water-soluble mixture, including 20 g of cannabidiol, 77.18 g of poloxamer (P407), 2.2 g of mannitol, 0.34 g of EDTA-disodium, and 0.28 g of malic acid.

[0102] (2) Cannabidiol, poloxamer (P407), mannitol, EDTA-disodium and malic acid were placed in a glass container and stirred at room temperature (25±5°C) until they were uniform. The stirring time of the first stage stirring was 10 min and the stirring speed was 700±50 r / min.

[0103] (3) Raise the temperature to 75° C. and carry out the second stage of stirring. The stirring time of the second stage of stirring is 5 hours, and the stirring speed is 700±50 r / min, until the cannabidiol and poloxamer are melted.

[0104] (4) Cool to room temperature (25±5°C) for solidification, and pulverize to obtain a mixture product; the mixture product is a white powder (similar to Example 1).

[0105] (5) 330 mg of the mixture product was added into 2 mL of water and dissolved. The solution was colorless, clear and transparent (similar to Example 1). The solubility of CBD was 33 mg / mL.

[0106] Comparative Example 1

[0107] (1) Provide the raw materials required for the water-soluble mixture, including 20 g of cannabidiol and 80 g of poloxamer (P407).

[0108] (2) Cannabidiol and poloxamer (P407) were placed in a glass container and stirred at room temperature (25±5°C) until they were uniform. The stirring time of the first stage of stirring was 10 min and the stirring speed was 700±50 r / min.

[0109] (3) Raise the temperature to 75° C. and carry out the second stage of stirring. The stirring time of the second stage of stirring is 5 hours, and the stirring speed is 700±50 r / min, until the cannabidiol and poloxamer are melted.

[0110] (4) cooling to room temperature (25±5°C) for solidification, and pulverizing to obtain a mixture product; Figure 5 As shown, the mixed product is a purple powder, and CBD is converted into anthraquinone substances.

[0111] (5) Take 380 mg of the mixture and dissolve it in 2 mL of water. Figure 6 As shown, the solution is light purple, clear and transparent, and the solubility of CBD is 38 mg / mL.

[0112] Comparative Example 2

[0113] (1) Provide the raw materials required for the water-soluble mixture, including 20 g of cannabidiol, 77.39 g of poloxamer (P407), 2.2 g of mannitol, 0.05 g of EDTA-disodium, and 0.36 g of citric acid.

[0114] (2) Cannabidiol, poloxamer (P407), mannitol, EDTA-disodium and citric acid were placed in a glass container and stirred at room temperature (25±5°C) until they were uniform. The stirring time of the first stage stirring was 10 min and the stirring speed was 700±50 r / min.

[0115] (3) Raise the temperature to 75° C. and carry out the second stage of stirring. The stirring time of the second stage of stirring is 5 hours, and the stirring speed is 700±50 r / min, until the cannabidiol and poloxamer are melted.

[0116] (4) cooling to room temperature (25±5°C) for solidification, and pulverizing to obtain a mixture product; Figure 7 As shown, the mixed product is a purple powder, and CBD is converted into anthraquinone substances.

[0117] (5) Take 300 mg of the mixture and dissolve it in 2 mL of water. Figure 8 As shown, the solution is light purple, clear and transparent, and the solubility of CBD is 30 mg / mL.

[0118] Comparative Example 3

[0119] (1) Provide the raw materials required for the water-soluble mixture, including 20 g of cannabidiol, 77.41 g of poloxamer (P407), 2.2 g of mannitol, 0.34 g of EDTA-disodium, and 0.05 g of citric acid.

[0120] (2) Cannabidiol, poloxamer (P407), mannitol, EDTA-disodium and citric acid were placed in a glass container and stirred at room temperature (25±5°C) until they were uniform. The stirring time of the first stage stirring was 10 min and the stirring speed was 700±50 r / min.

[0121] (3) Raise the temperature to 75° C. and carry out the second stage of stirring. The stirring time of the second stage of stirring is 5 hours, and the stirring speed is 700±50 r / min, until the cannabidiol and poloxamer are melted.

[0122] (4) cooling to room temperature (25±5°C) for solidification, and pulverizing to obtain a mixture product; Fig. 9 As shown, the mixed product is a purple powder, and CBD is converted into anthraquinone substances.

[0123] (5) Take 310 mg of the mixture and dissolve it in 2 mL of water. Fig.10 As shown, the solution is light purple, clear and transparent, and the solubility of CBD is 31 mg / mL.

[0124] Comparative Example 4

[0125] (1) Provide the raw materials required for the water-soluble mixture, including 20 g of cannabidiol, 78.66 g of poloxamer (P407), 0.5 g of mannitol, 0.34 g of EDTA-disodium, and 0.5 g of citric acid.

[0126] (2) Cannabidiol, poloxamer (P407), mannitol, EDTA-disodium and citric acid were placed in a glass container and stirred at room temperature (25±5°C) until they were uniform. The stirring time of the first stage stirring was 10 min and the stirring speed was 700±50 r / min.

[0127] (3) Raise the temperature to 75° C. and carry out the second stage of stirring. The stirring time of the second stage of stirring is 5 hours, and the stirring speed is 700±50 r / min, until the cannabidiol and poloxamer are melted.

[0128] (4) Cooling to room temperature (25±5° C.) for solidification, and pulverizing to obtain a mixture product; the mixture product is a purple powder (similar to Comparative Example 3), and CBD is converted into anthraquinone substances.

[0129] (5) 310 mg of the mixture product was added into 2 mL of water and dissolved. The solution was light purple, clear and transparent (similar to Comparative Example 3). The solubility of CBD was 31 mg / mL.

[0130] Comparative Example 5

[0131] (1) Provide the raw materials required for the water-soluble mixture, including 20 g of cannabidiol, 79.61 g of poloxamer (P407), 0 g of mannitol, 0.34 g of disodium EDTA, and 0.05 g of citric acid.

[0132] (2) Cannabidiol, loxamer (P407), EDTA-disodium and citric acid were placed in a glass container and stirred at room temperature (25±5°C) until they were uniform. The stirring time of the first stage was 10 min and the stirring speed was 700±50 r / min.

[0133] (3) Raise the temperature to 75° C. and carry out the second stage of stirring. The stirring time of the second stage of stirring is 5 hours, and the stirring speed is 700±50 r / min, until the cannabidiol and poloxamer are melted.

[0134] (4) Cooling to room temperature (25±5° C.) for solidification, and pulverizing to obtain a mixture product; the mixture product is a purple powder (similar to Comparative Example 3), and CBD is converted into anthraquinone substances.

[0135] (5) 310 mg of the mixture product was added into 2 mL of water and dissolved. The solution was colorless, clear and transparent (similar to Comparative Example 3). The solubility of CBD was 31 mg / mL.

[0136] Comparative Example 6

[0137] (1) Provide the raw materials required for the water-soluble mixture, including 20 g of cannabidiol, 77.75 g of poloxamer (P407), 2.2 g of mannitol, 0 g of EDTA-disodium, and 0.05 g of citric acid.

[0138] (2) Cannabidiol, poloxamer (P407), mannitol and citric acid were placed in a glass container and stirred at room temperature (25±5°C) until they were uniform. The stirring time of the first stage was 10 min and the stirring speed was 700±50 r / min.

[0139] (3) Raise the temperature to 75° C. and carry out the second stage of stirring. The stirring time of the second stage of stirring is 5 hours, and the stirring speed is 700±50 r / min, until the cannabidiol and poloxamer are melted.

[0140] (4) Cooling to room temperature (25±5° C.) for solidification, and pulverizing to obtain a mixture product; the mixture product is a purple powder (similar to Comparative Example 3), and CBD is converted into anthraquinone substances.

[0141] (5) 310 mg of the mixture product was added into 2 mL of water and dissolved. The solution was colorless, clear and transparent (similar to Comparative Example 3). The solubility of CBD was 31 mg / mL.

[0142] Comparative Example 7

[0143] (1) Provide the raw materials required for the water-soluble mixture, including 20 g of cannabidiol, 77.46 g of poloxamer (P407), 2.2 g of mannitol, 0.34 g of EDTA-disodium, and 0 g of citric acid.

[0144] (2) Cannabidiol, poloxamer (P407), mannitol and EDTA-disodium are placed in a glass container and stirred at room temperature (25±5°C) until they are uniform. The stirring time of the first stage stirring is 10 min and the stirring speed is 700±50 r / min.

[0145] (3) Raise the temperature to 75° C. and carry out the second stage of stirring. The stirring time of the second stage of stirring is 5 hours, and the stirring speed is 700±50 r / min, until the cannabidiol and poloxamer are melted.

[0146] (4) Cooling to room temperature (25±5° C.) for solidification, and pulverizing to obtain a mixture product; the mixture product is a purple powder (similar to Comparative Example 3), and CBD is converted into anthraquinone substances.

[0147] (5) 310 mg of the mixture product was added into 2 mL of water and dissolved. The solution was colorless, clear and transparent (similar to Comparative Example 3). The solubility of CBD was 31 mg / mL.

[0148] Comparative Example 8

[0149] (1) Provide the raw materials required for the water-soluble mixture, including 2 g of cannabidiol, 96.78 g of poloxamer (P407), 1 g of mannitol, 0.1 g of EDTA-disodium, and 0.12 g of citric acid.

[0150] (2) Cannabidiol, poloxamer (P407), mannitol, EDTA-disodium and citric acid were placed in a glass container and stirred at room temperature (25±5°C) until they were uniform. The stirring time of the first stage stirring was 10 min and the stirring speed was 700±50 r / min.

[0151] (3) Raise the temperature to 75° C. and carry out the second stage of stirring. The stirring time of the second stage of stirring is 5 hours, and the stirring speed is 700±50 r / min, until the cannabidiol and poloxamer are melted.

[0152] (4) cooling to room temperature (25±5°C) for solidification, and pulverizing to obtain a mixture product; Fig.11 As shown, the mixture product is a white powder.

[0153] (5) Take 330 mg of the mixture and dissolve it in 2 mL of water. Fig.12 As shown, the solution is colorless, clear and transparent, and the solubility of CBD is 3.3 mg / mL.

[0154] Comparative Example 9

[0155] (1) Provide the raw materials required for the water-soluble mixture, including 40 g of cannabidiol, 55.82 g of poloxamer (P407), 2.9 g of mannitol, 0.48 g of EDTA-disodium, and 0.7 g of citric acid.

[0156] (2) Cannabidiol, poloxamer (P407), mannitol, EDTA-disodium and citric acid were placed in a glass container and stirred at room temperature (25±5°C) until they were uniform. The stirring time of the first stage stirring was 10 min and the stirring speed was 700±50 r / min.

[0157] (3) Raising the temperature to 75°C and carrying out the second stage of stirring. The stirring time of the second stage of stirring is 5 hours, the stirring speed is 700±50r / min, and the solid is not melted, and a mixture product is obtained. Fig.13 As shown, the mixture product is a white paste.

[0158] (4) Take 330 mg of the mixture and dissolve it in 2 mL of water. Fig.14 As shown, the mixture product did not dissolve and the solution was turbid.

[0159] It can be seen from Table 1 that within the range of the ratio parameters of the present application, the shape of the prepared mixture product is white powder, and the solubility of CBD in the mixture can reach 20-40 mg / mL, with good solubility.

[0160] The maximum solubility of the mixture product prepared in the present application in water is about 170 mg / ml, so the solubility of the converted CBD will increase with the increase of the CBD content in the mixture product (white powder). Of course, other added ingredients (such as poloxamer, stabilizer, metal complex or organic acid) will also have an impact, but the impact is not significant.

[0161] From the results of Example 15 to Example 18, it can be seen that within the range of the ratio parameters of the present application, when the poloxamer, stabilizer, metal complex or organic acid is replaced, such as different types of poloxamer, different stabilizers, metal complexes or organic acids, the prepared mixture product has a good shape and good water solubility.

[0162] Combining the results of Example 1 with Comparative Examples 1 to 4, it can be seen that when the addition amount of at least one of the stabilizer, metal complex or organic acid is reduced, the chemical properties of CBD in the mixture product are unstable, resulting in changes in the chemical structure to generate purple anthraquinone compounds. The final mixture product has good water solubility, but turns purple, which does not meet the product requirements.

[0163] Combining the results of Example 1 with Comparative Example 1 and Comparative Example 5 to Comparative Example 7, it can be seen that when at least one of the stabilizer, metal complex or organic acid is not added, the chemical properties of CBD in the mixture product are unstable, resulting in changes in the chemical structure to generate purple anthraquinone compounds. The final mixture product has good water solubility, but turns purple, which does not meet the product requirements.

[0164] Combining the results of Example 1 with Comparative Examples 8 to 9, it can be seen that when the CBD content in the mixture product decreases, especially when it is less than 10%, the proportion of poloxamer increases, and the solubility of the mixture product is good, but the converted CBD solubility decreases, which does not meet the product requirements; when the CBD content in the mixture product increases, especially when it is higher than 30%, the proportion of poloxamer decreases, poloxamer cannot completely encapsulate CBD, the solubility of the mixture product decreases or cannot be dissolved, and does not meet the product requirements.

[0165] In summary, the present application uses CBD, poloxamer, a stabilizer (such as mannitol), an organic acid (citric acid) and a metal complex (such as disodium EDTA) as raw materials, and adopts a melting method for preparation. The CBD in the prepared mixture product has good water solubility, and no organic solvent is added during the preparation process, which has better safety. The preparation process is simple to operate, and the obtained product has a good shape and is easy to use.

[0166] At the same time, the prepared mixture product does not affect the original properties of CBD. When combined with poloxamer, it synergistically increases the water solubility of CBD. Compared with the water solubility of CBD itself, the water solubility can reach 20-40 mg / mL; it is easy to prepare solid preparations later.

[0167] The water-soluble mixture and the preparation method thereof provided in the examples of the present application are introduced in detail above. Specific examples are used herein to illustrate the principles and implementation methods of the present application. The description of the above embodiments is only used to help understand the method of the present application and its core idea. At the same time, for technicians in this field, according to the idea of ​​the present application, there will be changes in the specific implementation method and application scope. In summary, the content of this specification should not be understood as a limitation on the present application.

Claims

1. A water-soluble mixture, characterized in that The water-soluble mixture comprises, by weight: Cannabidiol 100-300 parts; Poloxamer 657-887 parts.

2. The water-soluble mixture according to claim 1, characterized in that The ratio of the mass fraction of the poloxamer to the mass fraction of the cannabidiol ranges from 2 to 9.

3. The method according to claim 1, characterized in that: The poloxamer includes one or both of poloxamer 188 and poloxamer 407.

4. The water-soluble mixture according to any one of claims 1 to 3, characterized in that The ratio of the mass fraction of the poloxamer to the mass fraction of the cannabidiol ranges from 2.19 to 5.

5.

5. The water-soluble mixture according to any one of claims 1 to 3, characterized in that The water-soluble mixture comprises, by weight:

6. The water-soluble mixture according to claim 5, characterized in that The water-soluble mixture comprises, by mass percentage:

7. The water-soluble mixture according to claim 5, characterized in that The stabilizer includes one or more of glycerol, mannitol, erythritol, sorbitol, maltitol, lactitol, and xylitol.

8. The water-soluble mixture according to claim 5, characterized in that The metal complex comprises one or more of disodium ethylenediaminetetraacetate, pentasodium diethylenetriaminepentaacetate, trisodium nitrilotriacetate, and tetrasodium ethylene glycol bis(2-aminoethyl ether)tetraacetate.

9. The water-soluble mixture according to claim 5, characterized in that The organic acid includes one or more of formic acid, acetic acid, propionic acid, butyric acid, valeric acid, caproic acid, caprylic acid, capric acid, citric acid, lauric acid, myristic acid, palmitic acid, stearic acid, oleic acid, linoleic acid, linolenic acid, phenylacetic acid, benzoic acid, pyruvic acid, levulinic acid, tartaric acid, lactic acid, malonic acid, succinic acid, fumaric acid, gluconic acid, saccharic acid, salicylic acid, sorbic acid, malonic acid, and malic acid.

10. A method for preparing a water-soluble mixture, characterized in that: The preparation method comprises: Provide at least cannabidiol and poloxamer; Melting the cannabidiol and poloxamer to obtain a material to be solidified; The material to be solidified is cooled and solidified to obtain the water-soluble mixture.